Labcorp Enters into Agreement with OPKO Health to Acquire Select Assets of BioReference Health
PR Newswire•15/10/2026•07:30 ET
0
Key Highlights
- ➤Labcorp (LH) to acquire select BioReference assets for $722 million cash at closing
- ➤Transaction includes over 80 patient service centers and BioReference specialty testing businesses
- ➤Labcorp may pay up to $150 million earnout tied to 4Kscore Test revenue
- ➤Acquired business expected to generate approximately $250 million first-year revenue
- ➤OPKO Health (OPK) will streamline operations and focus resources on its biopharmaceutical business
Expert Statements
Bryan Vaughn, Executive Vice President and President of Diagnostics at Labcorp
“This acquisition strengthens our ability to deliver affordable, high-quality, specialized diagnostic services to more patients and providers around the country”
Bryan Vaughn, Executive Vice President and President of Diagnostics at Labcorp
“By expanding our clinical, women's health, urology and corrections testing capabilities and broadening access to innovative diagnostics such as the FDA-approved 4Kscore Test, we can help providers make more informed decisions, improve patient care and increase access to the comprehensive laboratory services people need to live healthier lives.”
Phillip Frost, M.D., Chairman and Chief Executive Officer of OPKO
“This transaction will allow OPKO to streamline operations and focus our resources on our biopharmaceutical business.”
Phillip Frost, M.D., Chairman and Chief Executive Officer of OPKO
“Labcorp's national scale and capabilities will broaden patient and provider access to BioReference's 4Kscore Test to many more patients across the country.”
Phillip Frost, M.D., Chairman and Chief Executive Officer of OPKO
“We believe this transaction is an important catalyst to further unlock additional value for our shareholders.”
Labcorp Enters into Agreement with OPKO Health to Acquire Select Assets of BioReference Health PR Newswire
Acquisition will expand access to clinical laboratory services, including a broad specialty testing menu for patients and providers nationwide
Get started
Create a free account to read the full story.